Value-based price for access (VBPA) may increase access of specialty drugs for patients.
Jeremy Bahr
Advertisement
Principal, Leavitt Partners, an HMA Company
Articles by Jeremy Bahr
Advertisement
Latest Updated Articles
Advertisement
Advertisement
- News
- Academy
- Multimedia
- Conferences
- Publications
- Partner Perspectives
- Resources
- Subscribe